Evaluate JNJ stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in JNJ? | Glauxie AI

Q: What are the risks of investing in JNJ?

Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry (Healthcare sector). The company is led by CEO Joaquin Duato. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health... Employees: 138,200.

Q: How much debt does JNJ have?

Review JNJ total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is JNJ a good long-term investment?

Evaluate JNJ as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in JNJ?

🦉

Johnson & Johnson (JNJ)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - General

CEOJoaquin Duato

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the...

Key Executives

Name	Title
Darren Snellgrove	Vice President of Investor Relations
Dirk Brinckman	Chief Compliance Officer
Elizabeth Forminard	Executive Vice President & Chief Legal Officer
Guy J. Lebeau	Group Chairman of MD&D Business - EMEA
James Swanson	Executive Vice President & Chief Information Officer
Jennifer L. Taubert	Executive Vice President & Worldwide Chairman of Innovative Medicine

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

JNJ Profile Financials

Is JNJ stock safe? How much debt does JNJ have? Is JNJ a good long-term investment?